$53.83 0.1 0.1%
Last Trade - 17/11/17
| Market Cap | £n/a |
| Enterprise Value | £n/a |
| Revenue | £575.1m |
| Position in Universe | th / 7396 |
| Industry | Market | |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
| Year End 31st Dec | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017E | 2018E | CAGR / Avg | |
|---|---|---|---|---|---|---|---|---|---|---|
| 370.3 | 450.8 | 520.6 | 436.2 | 768.3 | 803.4 | 799 | 831.7 | +16.8% | ||
| -39.1 | -1.7 | +3.0 | -17.1 | +8.65 | ||||||
|
x
|
||||||||||
| Profitability | ||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
| Cashflow | ||||||||||
| Dividends | ||||||||||
| Balance Sheet | ||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing % | |||
| Net Gearing % | |||
| Cash / Assets % |
| Liquidity (ttm) | ||
|---|---|---|
| Curr. Ratio | ||
| Quick Ratio | ||
| Interest Cov. | ||
| Efficiency (ttm) | ||
|---|---|---|
| Asset Turnover | ||
| Recs Turnover | ||
| Stock Turnover | ||
| Latest interim period vs. prior period | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
| 3yr Compound Annual Growth Rate | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
Revenue
Net Income
Normalised EPS
PE Ratio Range
Dividend Yield Range
|
Price Target:
( below Price)
|
31st Dec 2022
|
31st Dec 2023
|
||||
|---|---|---|---|---|---|---|
| Est. Long Term Growth Rate: |
Net Profit () |
EPS () |
DPS () |
Net Profit () |
EPS () |
DPS () |
| Consensus Estimate | ||||||
| 1m Change | ||||||
| 3m Change | ||||||
The Advisory Board Company is a United States-based provider of insight-driven performance improvement solutions to the rapidly changing health care and education industries. The Company offers subscription-based membership programs, software and data-enabled services for leaders in the health care industry by providing provocative insights, actionable strategies, and practical tools to support execution. It partners with 4,500 organizations spanning the health care ecosystem to understand where the industry is going and uncover solutions to tough problems. Its 200+ experts works on the issues and share their knowledge in a multitude of ways. Its advisory services covers topics, such as clinical quality, clinical services, healthcare workforce, health plan, nursing, operational efficiency, patient and consumer experience, physician, technology, and total cost of care.
| Last Annual | December 31st, 2016 |
| Last Interim | September 30th, 2017 |
| Incorporated | August 9, 2001 |
| No. of Shareholders: | 9 |
| No. of Employees: | 3,800 |
| Sector | Consumer Cyclicals |
| Industry | Media & Publishing |
| Index | |
| Exchange | NASDAQ Global Select Market |
| Shares in Issue | 40,758,952 |
| Free Float | (0.0%) |
| Eligible for |
✓
ISAs
✓
SIPPs
|
| Address | 2445 M St NW, WASHINGTON, 20037-1435, United States |
| Web | https://www.advisory.com/ |
| Phone | +1 202 2665600 |
| Contact | Robert Borchert (VP,IR Contact Officer) |
| Auditors | Ernst & Young LLP |
As of 17/11/17, shares in Advisory Board Co are trading at $53.83, giving the company a market capitalisation of £n/a. This share price information is delayed by 15 minutes.
Shares in Advisory Board Co are currently trading at $53.83 and the price has moved by 50.77% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Advisory Board Co price has moved by 22.84% over the past year.
Of the analysts with advisory recommendations for Advisory Board Co, there are there are currently 1 "buy" , 11 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Advisory Board Co is Hold. You can view the full broker recommendation list by unlocking its StockReport.
Advisory Board Co is scheduled to issue upcoming financial results on the following dates:
Advisory Board Co does not currently pay a dividend.
Advisory Board Co does not currently pay a dividend.
Advisory Board Co does not currently pay a dividend.
To buy shares in Advisory Board Co you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
Shares in Advisory Board Co are currently trading at $53.83, giving the company a market capitalisation of £n/a.
Here are the trading details for Advisory Board Co:
We were not able to load our ranking data for Advisory Board Co
We were not able to load any forecast data for Advisory Board Co.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Advisory Board Co. Over the past six months, the relative strength of its shares against the market has been -0.53%. At the current price of $53.83, shares in Advisory Board Co are trading at % against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
We were not able to find PE ratio data for Advisory Board Co.
We were unable to find the directors for Advisory Board Co.
Here are the top five shareholders of Advisory Board Co based on the size of their shareholding:
